Q3 2023 · 13F-HR
BVF INC/ILholdings as filed
Filed 2023-11-14 · accession 0000921895-23-002623
$3.71B
Reported value
69
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $1.24B | 33.4% | 21,751,284 | Common | SHARED |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $181.6M | 4.90% | 4,004,613 | Common | SHARED |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $148.9M | 4.02% | 2,131,100 | Common | SHARED |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $142.5M | 3.84% | 5,283,489 | Common | SHARED |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $138.1M | 3.72% | 4,370,024 | Common | SHARED |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $112.8M | 3.04% | 9,135,893 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $110.2M | 2.97% | 3,981,212 | Common | SHARED |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $100.2M | 2.70% | 8,291,988 | Common | SHARED |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $95.8M | 2.58% | 5,744,848 | Common | SHARED |
| G3855L106 | GHRS | GH RESEARCH PLC | $93.2M | 2.51% | 9,275,158 | Common | SHARED |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $88.2M | 2.38% | 1,750,000 | Common | SHARED |
| 730541109 | — | POINT BIOPHARMA GLOBAL INC | $70.5M | 1.90% | 10,563,748 | Common | SHARED |
| 36315X101 | LKFT | GALAPAGOS NV | $66.2M | 1.78% | 1,915,109 | Common | SHARED |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $65.9M | 1.78% | 4,739,004 | Common | SHARED |
| N5749R100 | 2GH | MERUS N V | $64.9M | 1.75% | 2,752,420 | Common | SHARED |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $62.4M | 1.68% | 1,827,958 | Common | SHARED |
| 50127T109 | KURA | KURA ONCOLOGY INC | $61.4M | 1.66% | 6,730,983 | Common | SHARED |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $58.9M | 1.59% | 9,103,054 | Common | SHARED |
| 98419J206 | XOMA | XOMA CORP DEL | $51.2M | 1.38% | 3,633,743 | Common | SHARED |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $51.0M | 1.38% | 4,007,413 | Common | SHARED |
| 00461U105 | ACRS | ACLARIS THERAPEUTICS INC | $48.4M | 1.30% | 7,064,736 | Common | SHARED |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $46.2M | 1.24% | 4,579,818 | Common | SHARED |
| 90240B106 | TYRA | TYRA BIOSCIENCES INC | $37.7M | 1.02% | 2,739,595 | Common | SHARED |
| 98985Y108 | ZYME | ZYMEWORKS INC | $37.2M | 1.00% | 5,870,000 | Common | SHARED |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $36.7M | 0.99% | 2,143,036 | Common | SHARED |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $32.0M | 0.86% | 2,742,409 | Common | SHARED |
| 230031106 | CGEM | CULLINAN ONCOLOGY INC | $28.9M | 0.78% | 3,196,701 | Common | SHARED |
| 282559103 | ETNBGBP | 89BIO INC | $28.5M | 0.77% | 1,846,154 | Common | SHARED |
| 88427A107 | — | THIRD HARMONIC BIO INC | $27.9M | 0.75% | 4,365,933 | Common | SHARED |
| 29668H708 | EPIEUR | ESSA PHARMA INC | $27.0M | 0.73% | 8,748,629 | Common | SHARED |
| 690469101 | OVID | OVID THERAPEUTICS INC | $26.3M | 0.71% | 6,851,051 | Common | SHARED |
| 037326105 | ANTX | AN2 THERAPEUTICS INC | $25.1M | 0.68% | 1,563,963 | Common | SHARED |
| 528872302 | LXRX | LEXICON PHARMACEUTICALS INC | $21.8M | 0.59% | 19,995,332 | Common | SHARED |
| H00263105 | ACIU | AC IMMUNE SA | $21.2M | 0.57% | 7,428,379 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $19.9M | 0.54% | 2,365,805 | Common | SHARED |
| 01671P100 | ALLKGUSD | ALLAKOS INC | $19.4M | 0.52% | 8,552,417 | Common | SHARED |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $14.8M | 0.40% | 1,508,416 | Common | SHARED |
| 38000Q102 | GLYCEUR | GLYCOMIMETICS INC | $14.3M | 0.39% | 9,544,262 | Common | SHARED |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $14.1M | 0.38% | 1,521,948 | Common | SHARED |
| 46565G104 | 5E7 | ITEOS THERAPEUTICS INC | $13.8M | 0.37% | 1,259,476 | Common | SHARED |
| 45175G108 | — | IKENA ONCOLOGY INC | $13.7M | 0.37% | 3,169,164 | Common | SHARED |
| 92337C203 | VSTM | VERASTEM INC | $13.7M | 0.37% | 1,685,219 | Common | SHARED |
| 13124Q106 | — | CALLIDITAS THERAPEUTICS AB | $13.7M | 0.37% | 750,000 | Common | SHARED |
| 869367102 | — | SUTRO BIOPHARMA INC | $11.6M | 0.31% | 3,347,946 | Common | SHARED |
| 45258J102 | IMVT | IMMUNOVANT INC | $11.5M | 0.31% | 300,000 | Common | SHARED |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $9.8M | 0.26% | 1,813,633 | Common | SHARED |
| 92539P101 | — | VERVE THERAPEUTICS INC | $8.6M | 0.23% | 650,000 | Common | SHARED |
| 23284F105 | CTMX | CYTOMX THERAPEUTICS INC | $8.5M | 0.23% | 6,595,801 | Common | SHARED |
| 89854M101 | TCRX | TSCAN THERAPEUTICS INC | $7.7M | 0.21% | 2,989,474 | Common | SHARED |
| 471871103 | — | JASPER THERAPEUTICS INC | $6.9M | 0.19% | 9,900,000 | Common | SHARED |
| 171757107 | — | CIDARA THERAPEUTICS INC | $6.5M | 0.17% | 6,861,127 | Common | SHARED |
| 720795103 | PIRSEUR | PIERIS PHARMACEUTICALS INC | $6.1M | 0.17% | 20,609,863 | Common | SHARED |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $5.9M | 0.16% | 4,326,710 | Common | SHARED |
| H57830103 | — | NLS PHARMACEUTICS LTD | $4.0M | 0.11% | 5,747,126 | Common | SHARED |
| 24661P807 | DCTH | DELCATH SYS INC | $4.0M | 0.11% | 976,149 | Common | SHARED |
| 50107A104 | KRON1USD | KRONOS BIO INC | $3.8M | 0.10% | 2,905,043 | Common | SHARED |
| 92765F108 | RYI | VIRACTA THERAPEUTICS INC | $3.8M | 0.10% | 3,614,662 | Common | SHARED |
| 608550208 | MTEMEUR | MOLECULAR TEMPLATES INC | $3.4M | 0.09% | 532,038 | Common | SHARED |
| 75082Q105 | — | RAIN ONCOLOGY INC | $3.0M | 0.08% | 3,526,729 | Common | SHARED |
| 90466Y103 | — | UNICYCIVE THERAPEUTICS INC | $2.9M | 0.08% | 3,413,563 | Common | SHARED |
| 46124U107 | IVA | INVENTIVA SA | $2.9M | 0.08% | 686,040 | Common | SHARED |
| 221015100 | CRVS | CORVUS PHARMACEUTICALS INC | $2.0M | 0.05% | 1,370,947 | Common | SHARED |
| 34962G109 | TOCAEUR | FORTE BIOSCIENCES INC | $2.0M | 0.05% | 2,982,105 | Common | SHARED |
| 04522R200 | — | ASLAN PHARMACEUTICALS LTD | $1.9M | 0.05% | 1,049,999 | Common | SHARED |
| 60853G106 | MOLN | MOLECULAR PARTNERS AG | $1.8M | 0.05% | 443,221 | Common | SHARED |
| 4525EP101 | VTLUSD | IMMUNIC INC | $1.7M | 0.05% | 1,149,425 | Common | SHARED |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $1.5M | 0.04% | 2,312,200 | Common | SHARED |
| 76200L309 | RZLT | REZOLUTE INC | $251,876 | 0.01% | 190,815 | Common | SHARED |
| 09063M205 | BNOXN | BIONOMICS LIMITED | $127,904 | 0.00% | 47,372 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.